- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05007717
Data-informed Stepped Care (DiSC) to Improve Adolescent HIV Outcomes (UH3)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
UNAIDS '95-95-95' targets cannot be achieved without additional support for adolescents living with HIV (ALHIV) to increase retention in care and to support viral suppression. Risk prediction tools as well as a stepped care approach to care can support differentiation of ALHIV to different risk groups, and tailor care based on risk.
The investigators have conducted informative work with ALHIV, caregivers, healthcare workers (HCW) and policy makers, and has developed a clinical prediction tool to identify ALHIV at highest risk of not being retained in care and poor viral suppression that could be adapted to identify adolescents who may need more support in their care. Understanding how best to use the risk prediction tool as well as how to tailor services based on risk may ultimately result in more efficient HIV care services, as well as adequate support for ALHIV at highest risk of poor outcomes.
Building on that informative work, in this protocol, the investigators will conduct a Phase III cluster randomized controlled trial (cRCT) by implementing a data-informed stepped care (DiSC) intervention of ALHIV HIV treatment management in high-volume HIV clinics in Kenya.
The cRCT will be conducted at up to 24 HIV care and treatment facilities located in Kisumu, Homabay, Migori county in Western Kenya, in which approximately 2000 HIV positive adolescents and young adults ages 10-24 years enrolled in HIV care will be recruited in this study.
Clinics randomized to the DiSC intervention arm will use a data-driven system to assign ALHIV to different levels of care depending on their current and anticipated health care needs. The intervention will be delivered at the individual level by HCW providing routine care during routine HIV clinic visits. Clinics randomized to the control arm will continue with standard of care approaches for adolescent clinic visits (usually 1-3 monthly visits), regardless of health care needs and additional support as needed.
As secondary objectives, this study also aims to evaluate the effectiveness of the DiSC intervention on ALHIV cascade outcomes (adherence, viral non-suppression) and receiving differentiated HIV care based on health status evaluation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Homa Bay, Kenya
- Asumbi Health Centre
-
Homa Bay, Kenya
- Homa Hills Health Centre
-
Homa Bay, Kenya
- Kendu Adventist Hospital
-
Homa Bay, Kenya
- Marindi Sub County Referral Hospital
-
Homa Bay, Kenya
- Mbita District Hospital
-
Homa Bay, Kenya
- Rachuonyo District Hospital
-
Homa Bay, Kenya
- Rangwe Sub-District Hospital
-
Homa Bay, Kenya
- Shirikisho Health Centre
-
Homa Bay, Kenya
- Suba District Hospital
-
Kisumu, Kenya
- Nyabondo Mission Hospital
-
Kisumu, Kenya
- Nyahera Sub County Hospital
-
Kisumu, Kenya
- Nyang'oma Health Centre
-
Kisumu, Kenya
- Rabour Health Centre
-
Kisumu, Kenya
- St. Elizabeth Chiga
-
Migori, Kenya
- Awendo Sub County Hospital
-
Migori, Kenya
- Dede Health Centre
-
Migori, Kenya
- Godkwer
-
Migori, Kenya
- Macalder Mission Hospital
-
Migori, Kenya
- Migori County Mission Hospital
-
Migori, Kenya
- Nyamaraga Health Centre
-
Migori, Kenya
- Rongo Sub County Hospital
-
Migori, Kenya
- Sony Medical Centre
-
Migori, Kenya
- St. Joseph's Mission Hospital
-
Migori, Kenya
- Uriri Sub County Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- HIV-positive
- Enrolled in HIV care
- Provision of informed consent
- Willing and able to give informed consent
Exclusion Criteria:
- Not able or willing to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Data-informed Stepped Care (DiSC) arm
At intervention sites, HCW will assign ALHIV to different levels or intensity of HIV services depending on their current and anticipated health care needs.
The stepped care framework is designed to be flexible, to accommodate variable individual and social support services available at each facility.
|
The DiSC intervention is comprised of a data-driven system to assign adolescents to care based on their health needs and the different levels of care for each assignment group. The trajectory of services moves from a relative position of ALHIV autonomy to more intensive service provision. Intervention steps start with 1) multi-month refills or community treatment delivery (differentiated care); 2) a standard of care level for those with medical needs such as pregnancy or opportunistic infections or patient choice; 3) patient reminders/tracking and counseling and referral services for mental health needs; 4) case management of unsuppressed individuals, including enhanced counseling and case conference problem-solving |
|
No Intervention: Standard of care
Sites randomized to the control arm will continue with standard of care approaches for adolescent clinic visits (usually 1-3 monthly visits) regardless of health care needs and additional support as needed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Missed Visits
Time Frame: 12 months
|
We will evaluate retention using a definition of missed visit and calculate the proportion of scheduled visits that are missed.
Missed visits will be defined as a participant not seen within 30 days after each scheduled visit.
Each scheduled visit will be classified as missed versus not missed.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of Viral Load Results Showing Viral Non-suppression
Time Frame: 12 months
|
We will evaluate viral load test results and calculate the proportion of results that show non-suppression.
Viral non-suppression will be defined as having HIV RNA viral loads (VL) >1,000 copies per milliliter.
Each VL test result will be classified as VL suppressed vs. unsuppressed.
|
12 months
|
|
Proportion of Visit Intervals With Good Adherence
Time Frame: 12 months
|
We will evaluate adherence by calculating the number of pills dispensed divided by the number of days during an inter-visit interval.
A proportion of adherence greater than 0.8 will be classified as good adherence.
The level of adherence during the past inter-visit interval will be assessed at each visit.
|
12 months
|
|
Incidence Rate of Loss to Follow-up
Time Frame: 12 months
|
We will also analyze retention using loss to follow-up (LTFU).
LTFU will be defined as a participant not seen within 30 days of a scheduled visit and not return to care within the 12-month study period.
The incidence rate of LTFU is the ratio of the number of new cases of LTFU to the total time the study participants was at risk of LTFU.
The denominator is the sum of the time each participant (person-year) was observed, totaled for all participants.
|
12 months
|
|
Proportion of Visits Enrolled in Differentiated Care Services (Fast-track Visits)
Time Frame: 12 months
|
We will calculate the proportion of visits enrolled in differentiated care using two definitions.
The first is fast-track visit, which evaluates if participants are assigned to fast-track status during visits.
Each visit will be assessed as enrolled in differentiated care (assigned to fast-track) or not.
|
12 months
|
|
Proportion of Visits Enrolled in Differentiated Care Services (Multi-month Refills)
Time Frame: 12 months
|
We will calculate the proportion of visits enrolled in differentiated care using two definitions.
The second is multi-month prescription refills, which evaluates if participants are given multi-month refill intervals more than 3 months.
Each visit will be assessed as enrolled in differentiated care (given multi-month refills) or not.
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pamela K Kohler, RN, MPH, PhD, University of Washington
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00011096
- UH3HD096906 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiv
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Federal University of São PauloGilead SciencesCompleted
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RecruitingPrEP | HIV | HIV Prevention | PrEP UptakeUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingFeasibility | HIV Prevention | PrEP Uptake | Acceptability | HIV Self-testing | Male Partners of HIV-negative Postpartum WomenSouth Africa
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); University of BotswanaRecruitingPregnancy | HIV | Post-partum | HIV Antiretroviral Therapy (ART) AdherenceBotswana
Clinical Trials on Data-informed Stepped Care (DiSC)
-
Henry M. Jackson Foundation for the Advancement...Indiana Institute for Medical ResearchRecruitingMusic Therapy | Veterans | Chronic Musculoskeletal PainUnited States
-
Peter Lindenauer, MDBerkshire Medical CenterCompletedChronic Obstructive Pulmonary Disease | Angina, Stable | Congestive Heart FailureUnited States
-
Seattle Children's HospitalUniversity of WashingtonCompleted
-
Copenhagen University Hospital, HvidovreRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Denmark
-
Children's National Research InstituteBaylor College of Medicine; National Institute of Diabetes and Digestive and... and other collaboratorsCompletedDiabetes Mellitus, Type 1
-
University of LeipzigCompleted
-
Baylor College of MedicineCompletedObsessive-Compulsive Disorder | Anxiety Disorders | Generalized Anxiety Disorder | Autism Spectrum Disorder | Social Anxiety Disorder | Specific Phobia | Cognitive Behavioral TherapyUnited States
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)RecruitingChronic Pain | Posttraumatic Stress DisorderUnited States
-
Massachusetts General HospitalTerminated
-
Children's Hospital of PhiladelphiaCenters for Disease Control and PreventionCompletedStress Disorders, PosttraumaticUnited States